- Joined
- Nov 2, 2012
- Messages
- 321
- Reaction score
- 61
AD with 220 pathologists sold to Australian laboratory for 9x EBITDA.
Share Price & Information - ASX
Share Price & Information - ASX
AD with 220 pathologists sold to Australian laboratory for 9x EBITDA.
Share Price & Information - ASX
What a ridiculous price unless there is significant non-human capital involved (non-human book value).
Now these peon pathologists are OWNED by AUSTRALIAN CORPORATION!! FLEE PATHOLOGY NOW. BOYCOTT THE CAP!! DAMN THE ACADEMIC PATHOLOGISTS (DTAP)!!!
There is almost same amount of debt to be paid out of the proceeds.
It is paid first from the proceeds of an all cash buyout.I thought the debt was around 400 million. Usually, any outstanding debt is assumed by the buyer.